-
Catalogue Entry: Summary Safety Review - Oral Retinoid Products - Assessing the Potential...
Health Canada reviewed the potential risk of impotence (erectile dysfunction) with the use of oral retinoids because of a publication from the Netherlands that linked...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Over-the-Counter Products Containing Pseudoephedrine...
Summary Safety Review - Over-the-Counter Products Containing Pseudoephedrine - Assessing the Potential Risk of Inflammation and Injury of the Large Intestine due to Insufficient...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Over-the-counter topical acne products containing...
A safety review was carried out to evaluate a potential link between serious allergic reactions (hypersensitivity reactions) and over-the-counter acne products containing either...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Phenylephrine and acetaminophen - Drug-drug interaction
Health Canada initiated a safety review following a report by the European Medicines Agency about the potential drug-drug interaction between phenylephrine and acetaminophen....-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm...
Health Canada carried out a safety review to assess the risk of birth defects with the use of ondansetron, as part of routine health product monitoring and because this drug is...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Viscous Lidocaine 2% - Assessing the Potential Risk...
Health Canada carried out a safety review to assess the potential risk of severe side effects in infants and young children with the use of viscous lidocaine. The issue was...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - ULORIC (febuxostat) - Assessing a Possible Risk of...
Health Canada carried out a safety review after finding international cases of DRESS suspected of being linked with the use of Uloric (febuxostat). DRESS describes a group of...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Trifecta Heart Valve - Assessing the Potential Risk...
After reviewing an article about the wearing out of the Trifecta heart valve 34 months after it was implanted in a patient, Health Canada carried out a safety review of related...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Tramadol-containing Products - Assessing the...
The product information for tramadol warns of the risk of serious breathing problems when too much is taken. Health Canada's safety review on codeine (another opioid drug) to...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Topical Antiseptic Non-Prescription Chlorhexidine...
This safety review was carried out to look at the potential link between non-prescription topical antiseptic chlorhexidine products and serious allergic reactions, and to...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - TECFIDERA - Assessing the Potential Risk of Kidney Injury
Health Canada reviewed the risk of kidney injury with Tecfidera after finding international cases of this risk in patients treated with Tecfidera. These cases were found during...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Strontium - Risk of Heart and Circulatory Side Effects
The European Medicines Agency completed a safety review of strontium ranelate, a drug available by prescription only in Europe at a dose of 680 mg per day and used to treat...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors...
A safety review was done to evaluate the potential risk of acute kidney injury and the use of two SGLT2 inhibitors, Invokana (canagliflozin) or Forxiga (dapagliflozin). This...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin,...
Ketones are a type of waste product that the body creates when it breaks down fat to use for energy. If ketones begin to build up to toxic levels in the blood (a condition known...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin,...
The minerals stored within the bones help provide strength. Bones that have fewer minerals (less bone mineral density) are more likely to become brittle and break (fracture). A...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of a...
After receiving two Canadian case reports involving canagliflozin, Health Canada reviewed the potential risk of PRES in patients treated with SGLT2 inhibitors who have developed...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) -...
Health Canada reviewed this issue because a published study found a link between SSRI exposure during pregnancy and an increased risk of autism in children. Autism is a...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk...
Health Canada reviewed the potential risk of a type of skin reaction known as subacute cutaneous lupus erythematosus(SCLE) with the use of PPIs after a published article that...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Proton Pump Inhibitors - Assessing the Potential...
This safety review was carried out to look at new information in the scientific literature that has emerged since the completion of a previous review in 2012 about the risk of...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Summary Safety Review - Propecia (finasteride 1 mg) and Proscar (finasteride...
Health Canada carried out a safety review to look at the potential risk of seizures in patients taking finasteride after cases of seizures were published in the WHO...-
File available for download in the following formats:
- HTML